A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David M Nathan, MD
Massachusetts General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama-Birmingham
Birmingham, Alabama, United States
- Southwestern American Indian Center
Phoenix, Arizona, United States
- Veterans Medical Research Foundation, San Diego (san Diego Va)
San Diego, California, United States
- University of Colorado
Denver, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- South Florida Va Foundation (miami Va)
Miami, Florida, United States
- Atlanta Va Medical Center
Decatur, Georgia, United States
- Kaiser Permanente of Georgia
Duluth, Georgia, United States
- Pacific Health Research and Education Institute (va Pacific Islands)
Honolulu, Hawaii, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
- Medstar Health Research Institute
Hyattsville, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- International Diabetes Center
Minneapolis, Minnesota, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Nebraska
Omaha, Nebraska, United States
- University of New Mexico School of Medicine
Albuquerque, New Mexico, United States
- State University of New York (suny)-Downstate Medical Center
Brooklyn, New York, United States
- Columbia University Naomi Berrie Diabetes Center
New York, New York, United States
- Mount Sinai St. Luke'S Hospital
New York, New York, United States
- Albert Einstein College of Medicine
The Bronx, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University of North Carolina Diabetes Care Center
Durham, North Carolina, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Case Western Reserve University School of Medicine
Cleveland, Ohio, United States
- Kaiser Permanente Northwest
Portland, Oregon, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Baylor Endocrine Center
Dallas, Texas, United States
- University of Texas-Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Texas Health Science Center
San Antonio, Texas, United States
- Seattle Institute for Biomedical and Clinical Research
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2013
- Primary completion
- 30 Apr 2021
- Completion
- 30 Apr 2021
- Last update posted
- 10 Feb 2026
- Registered enrollment
- 7,850
- Registry id
- NCT01794143
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.